Generic diabetes pill put to the test against Brand-Name drug
NCT ID NCT07266779
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checked if a new generic pill for type 2 diabetes (ertugliflozin/metformin) works the same as the brand-name drug (Segluromet). Thirty-six healthy adults took a single dose of each pill in random order. The goal was to see if the body absorbs both drugs at similar levels, which would mean the generic is a safe and effective alternative.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Veeda Clinical Research Limited
Gujrat, Gujarat, 384205, India